-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $114 at Canaccord
-
-
-
-
-
-
-
BioMarin Reports First Quarter 2026 Financial and Operating Results
-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $105 at Barclays
-
-
-
-
-
-
-
Canaccord Genuity Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Buy
-
-
-
-
-
-
-
Bernstein's US Biotech 3Q25 Preview: 'Expect Beats from ALNY and REGN'
-
-
-
-
-
-
-
BioMarin Announces Completion of Acquisition of Inozyme
-
-
-
-
-
-
-
Oppenheimer upgrades BioMarin on long term outlook
-
1,237,397 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


